{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/3359311/divs/23","sourcedb":"PMC","sourceid":"3359311","divid":23,"text":"PBMCs from CF patients do not produce increased amounts of IL-1\u03b2.\nPBMCs from CF patients (n\u200a=\u200a17\u201320) and healthy controls (n\u200a=\u200a15\u201319) were primed with LPS (10 ng/ml) overnight and stimulated with P. aeruginosa PAO1 (MOI\u200a=\u200a1), P. aeruginosa PAO1 lacking exsA (MOI\u200a=\u200a1), ATP (5 mM), or Poly(dA:dT) (1 \u00b5g/ml) for 24 hours. P. aeruginosa lacking exsA was used as a type III secretion control in comparison with wild-type P. aeruginosa. Supernatants were assayed for (A) IL-1\u03b2 and (B) IL-8.","project":"bionlp-st-ge-2016-coref","namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}]}